Table V.
Characteristic | Clinical improvement (n = 2561; 90.1%) | LCI (n = 280; 9.9%) | P value |
---|---|---|---|
Age, years | 56 (45-66) | 59 (44-67) | .11 |
Female sex | 1772 (69) | 181 (65) | .12 |
Race | .2 | ||
White | 2021 (79) | 233 (83) | |
African American | 103 (4.0) | 11 (3.9) | |
Other | 437 (17) | 36 (13) | |
Ethnicity (Latino) | 120 (4.7) | 13 (4.6) | > .9 |
BMI | .2 | ||
Underweight (<18.5 kg/m2) | 19 (0.7) | 5 (1.8) | |
Normal (18.5-24.9 kg/m2) | 593 (23) | 70 (25) | |
Overweight (25-30 kg/m2) | 801 (31) | 91 (33) | |
Obese (>30 kg/m2) | 1144 (45) | 114 (41) | |
Anticoagulation | 304 (12) | 27 (9.6) | .3 |
Prior phlebitis | 273 (11) | 35 (13) | .3 |
Prior DVT | 133 (5.2) | 25 (8.9) | .01 |
Prior PE | 12 (1.6) | 1 (0.9) | > .9 |
Compression therapy before intervention | .029 | ||
Daily | 875 (34) | 72 (26) | |
Most days | 684 (27) | 91 (33) | |
Intermittent | 566 (22) | 64 (23) | |
None | 423 (17) | 51 (18) | |
CEAP classification | .008 | ||
C4 | 527 (21) | 44 (16) | |
C3 | 1316 (51) | 134 (48) | |
C2 | 718 (28) | 102 (36) | |
Symptoms | |||
Pain | 2472 (97) | 255 (92) | < .001 |
Varicosities | 2460 (97) | 258 (93) | .002 |
Edema | 1763 (69) | 165 (59) | < .001 |
Pigmentation | 447 (17) | 39 (14) | .13 |
Inflammation | 420 (16) | 29 (10) | .009 |
Induration | 245 (9.6) | 18 (6.5) | .087 |
Quality of life | |||
Heaviness | 1901 (74) | 99 (35) | < .001 |
Achiness | 2360 (92) | 158 (56) | < .001 |
Swelling | 2157 (85) | 137 (49) | < .001 |
Throbbing | 1513 (59) | 98 (35) | < .001 |
Itching | 1189 (47) | 105 (38) | .005 |
Appearance | 2392 (94) | 234 (84) | < .001 |
Impact on work | 2217 (87) | 173 (62) | < .001 |
VCSS before treatment | 7 (6-9) | 6 (5-8) | < .001 |
BMI, Body mass index; CEAP, Clinical-Etiological-Anatomical-Pathophysiological; DVT, deep vein thrombosis; LCI, lack of clinical improvement; PE, pulmonary embolism.
Data presented as median (interquartile range) or number (%).
Boldface P values represent statistical significance (P < .05).